Gemigliptin: Newer promising gliptin for type 2 diabetes mellitus

Gemigliptin: Newer promising gliptin for type 2 diabetes mellitus

The dipeptidyl peptidase-4 (DPP-4) inhibitors have facilitated the management of type 2 diabetes mellitus (T2DM) owing to their superior efficacy and safety with low incidence of adverse effects. Gemigliptin is a new member of this family of drugs, and studies have revealed certain advantages of gem...

Full description

Bibliographic Details
Main Authors: Manish Gutch, Abhay Joshi, Sukriti Kumar, Avinash Agarwal, Rajendra Kumar Pahan, Syed Mohd Razi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Dipeptidyl peptidase-4
gemigliptin
type 2 diabetes mellitus
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=6;spage=898;epage=902;aulast=Gutch

Internet

http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=6;spage=898;epage=902;aulast=Gutch

Similar Items